On 2 February 2026, Andaman Medical co-organised a focused industry seminar together with Nord Pacific Medical and Hong Kong Productivity Council (HKPC), bringing together companies looking for practical guidance on ASEAN medical device compliance.
As more MedTech companies look toward Southeast Asia for growth, many are seeking clearer direction on regulatory pathways, documentation requirements, and approval timelines across different ASEAN markets. The seminar was organised to address these challenges directly, providing practical insights, reducing uncertainty, and helping companies build realistic and compliant market entry strategies.
Held at the HKPC Building in Kowloon Tong, the seminar welcomed MedTech companies and industry professionals preparing to expand into the Southeast Asian market.
Clear and Practical Guidance on ASEAN Regulations
The seminar, titled “Navigating ASEAN Medical Device Compliance: Pathways to Market Access and Regulatory Success in the Southeast Asia Market”, was designed to provide clear and actionable insights for companies at different stages of growth.
During the session, our team covered:
- the overall structure of ASEAN medical device regulatory pathways
- key differences in requirements across major ASEAN markets
- core documentation needed for product registration
- practical considerations to minimise delays and regulatory risk
We also discussed how the ASEAN Medical Device Directive encourages regional alignment, while emphasising the importance of understanding country-specific expectations when planning submissions.
Active Engagement from the MedTech Community
One of the highlights of the morning was the level of interaction from participants. The room was filled with meaningful discussion, practical concerns, and forward-looking questions from Hong Kong’s MedTech community.
Participants raised questions about:
- product classification across different ASEAN jurisdictions
- realistic approval timelines
- local authorised representation requirements
- selecting appropriate regulatory strategies based on product type
Beyond technical questions, many participants were focused on how to plan their ASEAN expansion in a structured and practical way. It was clear that companies are not just exploring opportunities, but actively preparing for well-planned entry into the region.
The strong engagement throughout the session reflects the growing confidence of Hong Kong MedTech companies looking toward Southeast Asia as their next growth market. We look forward to continuing these conversations and supporting their next steps.
Looking Ahead
We extend our appreciation to the Hong Kong Productivity Council for their collaboration in organising this seminar.
Special thanks to our co-organisers and honourable speakers from Andaman Medical and Nord Pacific Medical for sharing valuable industry insights and hands-on expertise. We are also grateful to all participants and our dedicated team for contributing to the positive energy and thoughtful discussions throughout the session.
If you would like to explore how Andaman Medical can support your entry into Southeast Asia market, our team is ready to assist.
